Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2025-12-26 @ 3:53 AM
Study NCT ID:
NCT05132218
Status:
UNKNOWN
Last Update Posted:
2021-11-24
First Post:
2021-10-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer
Sponsor:
Peking University Cancer Hospital & Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-26
First Submit QC Date:
None
Study First Post Date:
2021-11-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-16
Last Update Post Date:
2021-11-24
Last Update Post Date Type:
ACTUAL